From 18-22 May 2025, Brussels, Belgium, hosted the 26th IFCC-EFLM EUROMEDLAB Congress of Clinical Chemistry and Laboratory Medicine and the 49th Annual Meeting of the Royal Belgian Society of Laboratory Medicine.

A high-level delegation representing the China Association of In-Vitro Diagnostics (CAIVD), the China Professional Community of Experimental Medicine (CPCEM), and CACLP was invited to attend and take part in global discussions shaping the future of the in-vitro diagnostics (IVD) industry.

The delegation included:

Prof. Haibo Song, Chairman of CAIVD, Director of the IVD Industrial Development Institute at SAEM, and Founder of CACLP

Prof. Hualiang Wang, MD, Ph.D., Professor and President of Shanghai Academy of Experimental Medicine, Chairman of the Experimental Medicine Branch of the National Health Industry Enterprise Management Association, Chief Editor of VIEW

Ms. Karen Dai, Executive Deputy Secretary of CAIVD, General Manager of CACLP

During the event, the delegation engaged in in-depth discussions with representatives from leading international organizations——the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). 

The topics covered Sino-European collaboration in the IVD field including standardization initiatives, and market access strategies, fostering new opportunities for high-quality global cooperation.

Spotlight on China’s IVD Industry

EUROMEDLAB 2025 also saw a strong presence from leading Chinese IVD companies. Their participation underscored the innovation, competitiveness, and global ambition of China's diagnostics sector.

Exhibiting companies included:

WANTAI BIOPHARM

 

ZYBIO

AUTOBIO

WONDFO

YHLO

DIRUI

 

URIT MEDICAL ELECTRONIC

DYMIND

MEDCAPTAIN

LIFOTRONIC

ORIENT GENE

 

MEDCONN

LIFERIVER

MINDRAY

SNIBE

MACCURA

 

KEYU BIOLOGICAL ENGINEERING

EDAN

 

ANBIO BIOTECHNOLOGY

 

CHEMCLIN DIAGNOSTICS

 

IMPROVE MEDICAL